Home/Type 2 Diabetes

    What Is Type 2 Diabetes?

    Causes, symptoms, diagnosis and treatment explained

    Dr. Emma Scott
    Dr. Emma Scott

    Endocrinologist

    Last reviewed: July 2026

    Type 2 Diabetes in Australia - Key Statistics

    1.3M

    Australians diagnosed

    85-90%

    Of all diabetes cases

    300

    Diagnosed every day

    500K

    Undiagnosed (estimated)

    What is Type 2 diabetes?

    Type 2 diabetes is a condition where blood glucose (sugar) is high because of insulin resistance. In people without diabetes, the pancreas produces insulin which acts to move glucose out of the blood and into the body cells where it is the main source of energy. In Type 2 diabetes the body cells become resistant to the action of insulin, and eventually the pancreas cannot produce enough insulin to keep glucose in the normal range.3,4

    Unlike in Type 1 diabetes, people with Type 2 diabetes usually continue to produce insulin, particularly in early stages. The problem is that the insulin doesn't work as effectively as it should.4

    Over time, high blood glucose can damage blood vessels and nerves, increasing the risk of heart disease, stroke, kidney disease, vision loss and nerve damage.5

    With treatment, Type 2 diabetes can be effectively managed with a combination of lifestyle change and medications. Some people can achieve remission of diabetes with weight loss and sustained lifestyle change.6,7

    Key facts

    Type 2 diabetes is the most common form of diabetes.1
    It usually develops gradually over many years.4
    Insulin resistance is the main underlying problem.4
    Many people have no symptoms when first diagnosed.8
    Early diagnosis reduces the risk of long-term complications.9
    Modern medications can protect the heart and kidneys as well as lower blood glucose.10

    Symptoms of Type 2 diabetes

    Many people have no symptoms during the early stages.

    When symptoms do develop, they may include:

    • • increased thirst
    • • frequent urination
    • • tiredness
    • • blurred vision
    • • slow-healing cuts
    • • frequent skin infections
    • • recurrent thrush
    • • unexplained weight loss (less common)
    • • numbness or tingling in the hands or feet.8,9

    If left untreated, symptoms usually worsen as blood glucose levels continue to rise.

    How is Type 2 diabetes diagnosed?

    Type 2 diabetes is diagnosed using blood tests. Your doctor may recommend:

    TestDiabetes result
    HbA1c≥6.5% (48 mmol/mol)11
    Fasting blood glucose≥7.0 mmol/L11
    Oral glucose tolerance test2-hour glucose ≥11.1 mmol/L11
    Random blood glucose (with symptoms)≥11.1 mmol/L11

    Early diagnosis allows treatment to begin before serious complications develop.9

    How does insulin normally work?

    After eating, carbohydrates are broken down into glucose, which enters the bloodstream. In response, the pancreas releases insulin, allowing glucose to move into the body's cells where it can be used for energy.3

    Insulin also tells the liver to stop releasing stored glucose into the bloodstream. Together, these processes keep blood glucose levels within a healthy range.3

    What happens in Type 2 diabetes?

    Type 2 diabetes develops gradually.

    Initially, the body's cells become less sensitive to insulin. This is called insulin resistance. To compensate, the pancreas produces increasing amounts of insulin.4

    Eventually, the insulin-producing beta cells become unable to keep up with demand. As insulin production falls, blood glucose levels begin to rise.4

    This process often starts years before symptoms appear, which is why many people are diagnosed during a routine blood test.8

    What is insulin resistance?

    Insulin resistance means the body's cells no longer respond normally to insulin. As a result:

    • • glucose stays in the bloodstream
    • • the pancreas works harder to produce more insulin
    • • blood glucose gradually rises
    • • beta cells become exhausted over time.4

    Who is at risk?

    Anyone can develop Type 2 diabetes, but the risk is higher if you:

    • • First degree relative with diabetes1
    • • Overweight or obese (BMI ≥ 25 kg/m² or ≥ 23 kg/m² in individuals of Asian ancestry)1
    • • Ethnicity and cultural background (including people of Aboriginal or Torres Strait Islander, Pacific Islander or South Asian background)1
    • • Physically inactive1
    • • History of gestational diabetes or polyendocrine metabolic ovarian syndrome (PMOS, previously known as PCOS)1
    • • Have high blood pressure or abnormal cholesterol10
    • • Over 40 years old1
    • • Smoking1

    You can check your risk with the Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK).

    Need Expert Care?

    Connect with qualified diabetes specialists in your area

    References

    1. International Diabetes Federation. IDF Diabetes Atlas. 11th ed. Brussels: International Diabetes Federation; 2025. Available from: https://diabetesatlas.org/
    2. Diabetes Australia. Type 2 diabetes.
    3. American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1).
    4. DeFronzo RA. From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus. Diabetes. 2009;58(4):773–795. Available from: https://diabetesjournals.org/diabetes/article/58/4/773/14067/From-the-Triumvirate-to-the-Ominous-Octet-A-New
    5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes. Lancet. 1998;352:837–853. Available from: https://www.thelancet.com/
    6. National Institute for Health and Care Excellence (NICE). Type 2 diabetes in adults: management (NG28).
    7. Davies MJ, Aroda VR, Collins BS, et al. Management of Hyperglycaemia in Type 2 Diabetes, 2025. A Consensus Report by the ADA and the EASD. Diabetes Care. Available from: https://diabetesjournals.org/care/
    8. Lean MEJ, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of Type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391:541–551. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)33102-1/fulltext
    9. Taylor R, Al-Mrabeh A, Zhyzhneuskaya S, et al. Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β-Cell Recovery. Cell Metabolism. 2018;28(4):547–556. Available from: https://www.cell.com/cell-metabolism/fulltext/S1550-4131(18)30354-1
    10. World Health Organization. Diabetes fact sheet.
    11. Royal Australian College of General Practitioners (RACGP). Management of Type 2 Diabetes: A handbook for general practice.
    12. American Diabetes Association Professional Practice Committee. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S27–S49.
    13. Zinman B, Wanner C, Lachin JM, et al. EMPA-REG OUTCOME Investigators. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015;373:2117–2128. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa1504720
    14. Marso SP, Daniels GH, Brown-Frandsen K, et al. LEADER Trial Investigators. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016;375:311–322. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa1603827
    15. Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. DAPA-CKD Trial Committees and Investigators. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020;383:1436–1446. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2024816
    16. American Diabetes Association. Retinopathy, Neuropathy and Foot Care. Standards of Care in Diabetes—2026.
    17. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). What Is Diabetes?
    18. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Your Pancreas & How It Works.
    19. Australian Diabetes Society. Type 2 Diabetes Management Algorithm.
    20. Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. N Engl J Med. 2002;346:393–403. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa012512

    Last reviewed: July 2026 · Next review due: July 2027

    This website content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition.